During the first 100 days, symptoms consistent with GVHD developed in 90% of cases but were often determined by centers to be due to causes other than GVHD. Indeed, GVHD was under consideration in ...
Single Digital Solution for All Clinical Trial Endpoints, Integrated with the Medidata Clinical Cloud™ A single solution that follows all clinical events from beginning to final outcome, Medidata ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, today announced the launch of Medidata Adjudicate, a state-of-the-art clinical endpoint adjudication system, fully integrated with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results